Domov › Ateroskleroza › Virginia
Klinične študije za Ateroskleroza v Virginia
9 študij za Ateroskleroza išče udeležence na lokacijah v Virginia.
Mesta v Virginia
Uradno besedilo študije (angleško)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Carient Heart & Vascular - Manassas, Manassas
- Carient Heart and Vascular LLC-Reston, Reston
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Virginia Heart, Falls Church
- Mary Washington Hospital, Fredericksburg
- Carient Heart & Vascular - Manassas, Manassas
- in še 6
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Inova Cardiology - Fairfax, Fairfax
- Virginia Heart, Falls Church
Vključevanje udeležencevFaza 3
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Virginia Heart, Falls Church
- Carilion Clinic, Roanoke
Vključevanje udeležencevFaza 3
Starost 45–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07613294Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DCR-Norfolk Great Bridge, Chesapeake
- Nephrology Associates of Northern Virginia Inc, Fairfax
- Peninsula Kidney Associates, Hampton
- in še 2
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Fairfax
- Research Site, Falls Church
- Research Site, Hopewell
- in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Virginia Heart, Falls Church
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Javara Research, Alexandria
- Javara Research, Alexandria
- Javara Research, Alexandria
- in še 4
Vključevanje udeležencevFaza 3
Starost 18–100 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06875973Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
- Salem VA Medical Center, Salem, VA, Salem
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 17. dec. 2025 · NCT02915198Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.